Golden Meditech Holdings Limited is an investment holding company. The Company is an integrated medical devices and healthcare services player in China. It is primarily engaged in the development, manufacture, sales and distribution of blood-related medical devices. It operates in two segments. Its medical devices segment is engaged in the development, manufacture, sales and distribution of blood-related medical devices. The Company is focused on blood recovery, purification, treatment, and preservation technologies. Its healthcare services segment focuses on hospital management and related services. Golden Meditech manages two haematology specialist hospitals in China. On March 9, 2011, the Company completed the acquisition of the remaining equity interests in CHI and its subsidiaries (the CHI Group). The principal activities of the acquired Company are the research and development, manufacture and sale of natural herbal medicines.